Oncology News and Research

RSS
Research finds possible explanation for why many cancer drugs don't work in human trials

Research finds possible explanation for why many cancer drugs don't work in human trials

Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy

Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

Researchers receive $4.5 million grant to support lung cancer screenings and research

Researchers receive $4.5 million grant to support lung cancer screenings and research

Objectives, challenges and opportunities of new IASLC Molecular Database Project

Objectives, challenges and opportunities of new IASLC Molecular Database Project

Giving chemotherapy in the morning can extend survival of glioblastoma patients

Giving chemotherapy in the morning can extend survival of glioblastoma patients

Cancer patients treated with immunotherapy at high risk of developing thrombotic complications

Cancer patients treated with immunotherapy at high risk of developing thrombotic complications

Key Milestone in Molded Glass: SGD Pharma Elevates Type I Offering with Three Tailored Product and Service Solutions

Key Milestone in Molded Glass: SGD Pharma Elevates Type I Offering with Three Tailored Product and Service Solutions

Survey: COVID-19 pandemic has led to more advanced-stage cancer diagnoses

Survey: COVID-19 pandemic has led to more advanced-stage cancer diagnoses

The Dream Team opens clinical trial to find better treatment options for pancreatic cancer

The Dream Team opens clinical trial to find better treatment options for pancreatic cancer

New machine learning technique reveals mutational signatures in cancer patients

New machine learning technique reveals mutational signatures in cancer patients

SwiftScale Biologics: Cell-Free Synthesis of Biologics

SwiftScale Biologics: Cell-Free Synthesis of Biologics

Study confirms the predictive value of molecular classification of hormone-sensitive breast cancer

Study confirms the predictive value of molecular classification of hormone-sensitive breast cancer

New approach can help identify patients at risk for esophageal cancer

New approach can help identify patients at risk for esophageal cancer

IQWiG releases revised version of its General Methods

IQWiG releases revised version of its General Methods

AI study on aggressive form of cancer could improve patient outcomes

AI study on aggressive form of cancer could improve patient outcomes

The pressure is on to diagnose and treat chronic kidney disease

The pressure is on to diagnose and treat chronic kidney disease

Mogrify wins Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at CambridgeshireLive Business Excellence Awards 2020

Mogrify wins Hewitsons Award for Innovation in Business and Price Bailey Award for Business of the Year at CambridgeshireLive Business Excellence Awards 2020

Moffitt researchers use mathematical modeling to help explain outcomes of CAR T-cell therapy

Moffitt researchers use mathematical modeling to help explain outcomes of CAR T-cell therapy

UCLA researchers receive NIH grants to identify new ways to treat pancreatic cancer

UCLA researchers receive NIH grants to identify new ways to treat pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.